+44 (0) 1698 534002
Contact

News

Ada Lovelace Day 2024 – celebrating and inspiring women in STEM

08 October 2024

Ada Lovelace Day is an international day of celebration that aims to raise the profile of women in STEM to inspire other...

Read more

Meet the team: Mhairi Matheson

07 October 2024

Mhairi is an experienced medicinal chemist, who has worked at BioAscent for the past six years, and recently transitione...

Read more

COLLABORATION BETWEEN ARKUDA THERAPEUTICS AND BIOASCENT IDENTIFIES NOVEL TRPML1 AGONISTS

27 September 2024

The team at Arkuda Therapeutics, a leading US-based biotechnology company, joined forces with BioAscent to discover nove...

Read more

A summer at BioAscent: building practical skills in drug discovery

25 September 2024

As summer draws to a close, we’re reflecting on the success of our summer placement programme and the contributions of t...

Read more

Highlights in Synthesis - Skeletal editing: a pioneering tool to accelerate drug discovery

10 September 2024

Skeletal editing has recently surfaced as a powerful strategy for precise and selective deletion, insertion or swapping...

Read more

Putting something back. Phil Jones talks about his role on the BMCS

02 September 2024

Members of the RSC’s Biological and Medicinal Chemistry Sector (BMCS), including BioAscent’s Chief Scientific Advisor Dr...

Read more

Growing UK biotech partners with BioAscent to enable the pooling and plating of in-house 85k library

21 August 2024

BioAscent, a leader in compound management, has successfully partnered with a growing UK biotech to enable the pooling o...

Read more

Medicines for Malaria Venture Reflects on Successful Compound Management Partnership with BioAscent

15 July 2024

Medicines for Malaria Venture (MMV), a virtual research organisation which plays a crucial role in malaria control and e...

Read more

US biotech uses BioAscent’s compound management service to accelerate screening of 250k library across multiple campaigns

08 July 2024

A US biotech company has partnered with compound management experts BioAscent to build, consolidate and manage its scree...

Read more

BioAscent team key part of collaborative European Lead Factory study to identify small molecule inhibitors of a DNA repair nuclease (SNM1A)

26 June 2024

The recently published paper, Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer t...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact